http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011203060-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd5ab29f0d041de89e4d36e513f62edf |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate | 2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a8fe72daed1541343172147f66a4c66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1619f487a0ec0b0b97edb55d4d020890 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_982add162d657a270b11bb1afbfc547e |
| publicationDate | 2013-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2011203060-A1 |
| titleOfInvention | Suppression of neuroendocrine diseases |
| abstract | 5 Suppression of neuroendocrine disease The present invention relates to a method for suppressing neuroendocrine disease. The therapy employs use of a non-cytotoxic protease, which is targeted to a neuroendocrine tumour cell, preferably 10 via a somatostatin or cortistatin receptor, a GHRH receptor, a ghrelin receptor, a bombesin receptor, a urotensin receptor a melanin concentrating hormone receptor 1; a KiSS-1 receptor or a prolactin releasing peptide receptor. When so delivered, the protease is internalised and inhibits secretion from said tumour cell. The present 15 invention also relates to polypeptides and nucleic acids for use in said methods. |
| priorityDate | 2009-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 932.